Introduction
Cefuroxime is a broad spectrum injectable antibiotic which is active against both Gram-positive and Gram-negative organisms being stable to most P-lactamases produced by bacteria (O'Callaghan et al., 1976) . It is effective in the treatment of a wide variety of infections, but its value in the prophylaxis of infection associated with abdominal surgery is still to be established. Other antibiotics have been used for prophylaxis in various dosage regimens and it is unclear which regimen is most appropriate (Strachan et al., 1977; Morran, McNaught and McCardle, 1978; Stone et al., 1976) . This trial was designed to determine the effect of cefuroxime sodium on the incidence of wound and chest infection following biliary surgery, and 2 dosage regimens were compared with an untreated control group. Samples of sputum and swabs from infected wounds were taken and subjected to routine microbiological examination.
Bile and serum samples were taken from some patients immediately after removal of the gallbladder. The cefuroxime concentrations in these samples were estimated by large plate microbiological assay as described by O'Callaghan and Harding (1977) . Results 
Patients
One hundred and twenty-four patients entered the trial. However 10 patients were not included in the analysis: 7 in group A did not complete the 3-day course of cefuroxime (this was mainly because of pain on injection but one patient developed an urticarial rash), one patient in group B died of a pulmonary embolus 3 days after surgery and 2 patients in group C were given antibiotics in error. Thus, the analysis was carried out on results from 35 patients in group A and 40 patients in group B and 39 patients in group C.
The groups were well matched for weight, height and age although there was an uneven distribution of males and females (see Table 1 ). They were also well matched for numbers of smokers in each group and patients with obstructive jaundice. There was no difference in the groups with respect to type of skin preparation, type of incision, suture material, length of scar or duration of surgery. However, more patients in group C underwent exploration of the common bile duct than did those in the other 2 groups.
Infections
Three patients (9%) in group A, one (2%) in group B and 11 (28%) in group C had wound infections (group B was significantly different from group C, P < 005 partition X2 test (Everitt, 1977) . The type of surgery which resulted in wound infections is detailed in Table 2 . One patient in group C had a septicaemia and another had a late infection. Exploration of the common bile duct in the presence of stones was associated with an increased risk of wound infection. Eight patients in group C underwent such a procedure, of whom 5 had wound infections; whereas there were only 6 wound infections from 31 patients in group C who did not have bile duct stones. One patient out of 9 in groups A and B had a wound infection after exploration of the common bile duct when stones were present.
No one organism was consistently isolated from the infected wounds: Staphylococcus pyogenes was most frequently isolated and the other isolates were coliforms.
Eight patients in group A (23 %), 10 in group B (25%) and 13 in group C (33%) had chest complications. In most cases no organism could be isolated and from the remainder the most frequently isolated organism was Haemophilus influenzae either alone or with Streptococcus pneumoniae.
All the infections are summarized in Table 3 . Fig. 1 . Cefuroxime bile concentrations averaged 8-5 mg/l for patients in group A and 24-6 mg/l for patients in group B. The cefuroxime concentrations in the serum taken at the same time as the bile samples averaged 21P5 mg/l and 67T7 mg/l for patient in group A and B respectively. Discussion
These results show that a 1P5 g i.v. dose of cefuroxime given during the anaesthetic induction greatly reduces the incidence of wound infection associated with biliary surgery, and that there is no benefit in continuing the treatment after operation. Burke (1961) showed in a series of animal experiments that the effective period of antibiotic protection was at the time of inoculation of the bacteria, therefore a postoperative course of antibiotic would not be expected to reduce the incidence of wound infection. Strachan et al. (1977) and Stone et al. (1979) have also shown that there is no clinical benefit from the postoperative administration of other cephalosporins. The present authors have shown a difference between the 2 antibiotic treatment groups and this may be related to the serum cefuroxime concentration during surgery; the serum concentration from the i.v. 1-5 g dose was considerably higher than that of the 750 mg i.m. group.
Although the incidence of wound infection in the control group was rather high at 28%, a broad definition of wound infection, as described by Polk and Lopez-Mayor (1969) , which includes wounds discharging serum as well as pus, was used. This is justified because the incidence of serous discharge was unevenly distributed throughout the 3 treatment groups and it was considered that the antibiotic influenced the occurrence.
The question of prophylaxis against chest infection is much less clear cut. One of the major problems in this area is to distinguish between true infection and atelectasis (Editorial, 1977) . Atelectasis is common after upper abdominal surgery and would not be affected by antibiotics. This problem is reflected in the widely varying incidence of postoperative chest complications reported by various authors: 81 % by Lazlo et al. (1973) ; 32% by Presley and Alexander-Williams (1974) ; 86% by Collins, Darke and Knowelden (1968) ; 75% by Hansen, Drablos and Steinert (1977) ; 21 % by Wightman (1968) ; 47% by Morran and McArdle (1980) ; and 33 % in the present study. This depends on the criteria used for assessment and would explain why the present study failed to show any benefit for the antibiotic group.
Cefuroxime has been shown to reduce greatly the incidence of wound infection after biliary surgery, and 1P5 g given i.v. is the dosage of choice. The value of cefuroxime in the prophylaxis of chest infections is not clear; more accurate methods to distinguish between chest infections and atelectasis must be used before further progress can be made.
